DOI QR코드

DOI QR Code

Digital Therapeutics for Obesity Care

비만 관리를 위한 디지털 치료제

  • Seo, Yoo Bin (Department of Family Medicine, Wonkwang University Sanbon Hospital)
  • 서유빈 (원광대학교 산본병원 가정의학과)
  • Received : 2022.09.14
  • Accepted : 2022.10.31
  • Published : 2022.12.31

Abstract

Digital therapeutics (DTx) are emerging as a novel solution to improve lifestyle and prevent non-communicable diseases. Obesity is a complex, multi-factorial, chronic condition that requires patient-centered lifestyle modification. DTx, such as mobile applications and wearables, may offer easily accessible, efficient, and personalized care in the field of obesity and metabolic diseases. Yet, there is controversy over its clinical usefulness. This review will provide a comprehensive overview of DTx, including its potential role and current limitation in obesity care, based on recent literature.

Keywords

References

  1. Dang A, Dang D, Rane P. The expanding role of digital therapeutics in the post-COVID-19 era. Open COVID J 2021;1:32-7. https://doi.org/10.2174/2666958702101010032
  2. Patel NA, Butte AJ. Characteristics and challenges of the clinical pipeline of digital therapeutics. NPJ Digit Med 2020;3:159. https://doi.org/10.1038/s41746-020-00370-8
  3. Kim M, Choi HJ. Digital therapeutics for obesity and eating-related problems. Endocrinol Metab (Seoul) 2021;36:220-8. https://doi.org/10.3803/EnM.2021.107
  4. Digital Therapeutics Alliance. A new category of medicine [Internet]. Digital Therapeutics Alliance. 2020 [cited 2022 Sep 12]; Available from: https://dtxalliance.org/understanding-dtx/
  5. Lyn R, Heath E, Dubhashi J. Global implementation of obesity prevention policies: a review of progress, politics, and the path forward. Curr Obes Rep 2019;8:504-16. https://doi.org/10.1007/s13679-019-00358-w
  6. Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism 2019;92:6-10. https://doi.org/10.1016/j.metabol.2018.09.005
  7. Ko HJ, Cho YJ, Kim KK, et al. COVID-19 and related social distancing measures induce significant metabolic complications without prominent weight gain in Korean adults. Front Med (Lausanne) 2022;9:951793.
  8. Senthilingam M. COVID-19 has made the obesity epidemic worse, but failed to ignite enough action. BMJ 2021;372:n411. https://doi.org/10.1136/bmj.n411
  9. Menn ER, Kvedar JC. Teledermatology in a changing health care environment. Telemed J 1995;1:303-8.
  10. Makin S. The emerging world of digital therapeutics. Nature 2019;573:S106-9. https://doi.org/10.1038/d41586-019-02873-1
  11. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403. https://doi.org/10.1056/NEJMoa012512
  12. Dang A, Arora D, Rane P. Role of digital therapeutics and the changing future of healthcare. J Family Med Prim Care 2020;9:2207-13. https://doi.org/10.4103/jfmpc.jfmpc_105_20
  13. Sepah SC, Jiang L, Peters AL. Long-term outcomes of a Web-based diabetes prevention program: 2-year results of a single-arm longitudinal study. J Med Internet Res 2015;17:e92. https://doi.org/10.2196/jmir.4052
  14. Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care 2011;34:1934-42. Erratum in: Diabetes Care 2013;36:3850. https://doi.org/10.2337/dc11-0366
  15. Statista. Projected size of the digital therapeutics market worldwide from 2016 to 2025 [Internet]. Statista. 2021 [cited 2022 Sep 12]; Available from: https://www.statista.com/statistics/997974/worldwide-digital-therapeutics-market-size/
  16. NICE. Evidence standards framework for digital health technologies: user guide [Internet]. NICE. 2019 [cited 2022 Sep 12]; Available from: https://www.nice.org.uk/Media/Default/About/what-we-do/our-programmes/evidence-standards-framework/user-guide.pdf
  17. Kim JW, Jang KJ, Hwang EW. Digital therapeutics [Internet]. Korea Institute of S&T Evaluation and Planning. 2020 [cited 2022 Sep 12]; Available from: https://www.kistep.re.kr/board.es?mid=a10306010000&bid=0031&&list_no=34994&act=view
  18. Afshin A, Babalola D, Mclean M, et al. Information technology and lifestyle: a systematic evaluation of Internet and mobile interventions for improving diet, physical activity, obesity, tobacco, and alcohol use. J Am Heart Assoc 2016;5:e003058. https://doi.org/10.1161/JAHA.115.003058
  19. Carter MC, Burley VJ, Nykjaer C, Cade JE. Adherence to a smartphone application for weight loss compared to website and paper diary: pilot randomized controlled trial. J Med Internet Res 2013;15:e32. https://doi.org/10.2196/jmir.2283
  20. Islam MM, Poly TN, Walther BA, Jack Li YC. Use of mobile phone app interventions to promote weight loss: meta-analysis. JMIR Mhealth Uhealth 2020;8:e17039. https://doi.org/10.2196/17039
  21. Beleigoli AM, Andrade AQ, Cancado AG, Paulo MN, Diniz MFH, Ribeiro AL. Web-based digital health interventions for weight loss and lifestyle habit changes in overweight and obese adults: systematic review and meta-analysis. J Med Internet Res 2019;21:e298. https://doi.org/10.2196/jmir.9609
  22. Patel ML, Wakayama LN, Bennett GG. Self-monitoring via digital health in weight loss interventions: a systematic review among adults with overweight or obesity. Obesity (Silver Spring) 2021;29:478-99. https://doi.org/10.1002/oby.23088
  23. Almalki M, Gray K, Sanchez FM. The use of self-quantification systems for personal health information: big data management activities and prospects. Health Inf Sci Syst 2015;3(Suppl 1 HISA Big Data in Biomedicine and Healthcare 2013 Con):S1. https://doi.org/10.1186/2047-2501-3-S1-S1
  24. McDonough DJ, Su X, Gao Z. Health wearable devices for weight and BMI reduction in individuals with overweight/obesity and chronic comorbidities: systematic review and network meta-analysis. Br J Sports Med 2021;55:917-25. https://doi.org/10.1136/bjsports-2020-103594
  25. Yen HY, Chiu HL. The effectiveness of wearable technologies as physical activity interventions in weight control: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 2019;20:1485-93. https://doi.org/10.1111/obr.12909
  26. Allen JK, Stephens J, Dennison Himmelfarb CR, Stewart KJ, Hauck S. Randomized controlled pilot study testing use of smartphone technology for obesity treatment. J Obes 2013;2013:151597.
  27. Sullivan DK, Goetz JR, Gibson CA, et al. Improving weight maintenance using virtual reality (Second Life). J Nutr Educ Behav 2013;45:264-8. https://doi.org/10.1016/j.jneb.2012.10.007
  28. Kodama S, Saito K, Tanaka S, et al. Effect of Web-based lifestyle modification on weight control: a meta-analysis. Int J Obes (Lond) 2012;36:675-85. https://doi.org/10.1038/ijo.2011.121
  29. Baer HJ, Rozenblum R, De La Cruz BA, et al. Effect of an online weight management program integrated with population health management on weight change: a randomized clinical trial. JAMA 2020;324:1737-46. https://doi.org/10.1001/jama.2020.18977
  30. Kim M, Kim Y, Go Y, et al. Multidimensional cognitive behavioral therapy for obesity applied by psychologists using a digital platform: open-label randomized controlled trial. JMIR Mhealth Uhealth 2020;8:e14817. https://doi.org/10.2196/14817
  31. Varela C, Oda-Montecinos C, Andres A, Saldana C. Effectiveness of web-based feedback interventions for people with overweight and obesity: systematic review and network meta-analysis of randomized controlled trials. J Eat Disord 2021;9:75. https://doi.org/10.1186/s40337-021-00432-6
  32. Podina IR, Fodor LA. Critical review and meta-analysis of multicomponent behavioral e-health interventions for weight loss. Health Psychol 2018;37:501-15. https://doi.org/10.1037/hea0000623
  33. Ghelani DP, Moran LJ, Johnson C, Mousa A, Naderpoor N. Mobile apps for weight management: a review of the latest evidence to inform practice. Front Endocrinol (Lausanne) 2020;11:412. https://doi.org/10.3389/fendo.2020.00412
  34. Castelnuovo G, Pietrabissa G, Manzoni GM, et al. Cognitive behavioral therapy to aid weight loss in obese patients: current perspectives. Psychol Res Behav Manag 2017;10:165-73. https://doi.org/10.2147/PRBM.S113278
  35. Cooper Z, Fairburn CG, Hawker DM. Cognitive-behavioral treatment of obesity: a clinician's guide. New York: Guilford Press; 2003.
  36. Dalle Grave R, Sartirana M, Calugi S. Personalized cognitive-behavioural therapy for obesity (CBT-OB): theory, strategies and procedures. Biopsychosoc Med 2020;14:5. https://doi.org/10.1186/s13030-020-00177-9
  37. Wilhelm S, Weingarden H, Ladis I, Braddick V, Shin J, Jacobson NC. Cognitive-behavioral therapy in the digital age: presidential address. Behav Ther 2020;51:1-14. https://doi.org/10.1016/j.beth.2019.08.001
  38. Kim HS. Apprehensions about excessive belief in digital therapeutics: points of concern excluding merits. J Korean Med Sci 2020;35:e373. https://doi.org/10.3346/jkms.2020.35.e373